Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (12172)	10/2/2003 10:04:09 AM
From: StockDung	Respond to of 19428

Israel Englander, Millennium's 55-year-old founder ALSO RUNS RIVERVIEW GROUP LLC AND IS ALSO FOND OF THE LONGEST RUNNING FRAUD IN CANADA CRYSTALLEX INTERNATIONAL CORPORATION CRYSTALLEX INTERNATIONAL ... Form: F-3 Filing Date: 10/25/2002 CRYSTALLEX INTERNATIONAL CORPORATION Organized under the Laws of Canada 13,211,749 Common Shares GCA Strategic Investment Fund Limited, a Bermuda corporation located in Bermuda ("GCA"), and Riverview Group, LLC, a New York limited liability company, may use this prospectus to resell up to an aggregate of 10,551,715 Crystallex common shares to be issued upon their conversion of certain convertible notes and exercise of certain warrants that Crystallex issued to them. Jerry Karel, ISO Profit Sharing Plan & Trust, ABC Retirement Plan & Trust, Walter Nathan, Carl & Associates, Hyla Marrow, Daniel Gooze, Louis Scatigna and Louise E. Todaro (as joint tenants), Lincoln Trust Company FBO Marc Gordon, IRA, Mitchell Mondry, and Michael Miller may use this prospectus to resell up to an aggregate of 2,460,034 Crystallex common shares to be issued upon their conversion of 5.5% convertible debentures and their exercise of certain warrants that Crystallex issued to them in connection with the convertible debentures. Alpine Capital Partners, Inc., a Delaware corporation, may use this prospectus to resell up to 200,000 Crystallex common shares to be issued upon its exercise of warrants that Crystallex has issued to it. The selling shareholders may sell all or any portion of these Crystallex common shares in one or more transactions through ordinary brokerage transactions, in private, negotiated transactions, or through any other means described in the section entitled "Plan of Distribution" beginning on page 14. Crystallex will not receive any sales proceeds when these selling shareholders convert their convertible notes or convertible debentures or sell their common shares, but Crystallex will receive the exercise price of any warrants that the selling shareholders exercise. Crystallex lists the common shares for trading on The American Stock Exchange and on The Toronto Stock Exchange under the symbol KRY.